News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
Product Info
Get A Quote

Cat. No:GM-87870MAB

Product:Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)


Cat. No. & Size
Get A Quote

GM-87870MAB-1mg / 1 mg

GM-87870MAB-5mg / 5 mg

GM-87870MAB-25mg / 25 mg

GM-87870MAB-50mg / 50 mg

GM-87870MAB-100mg / 100 mg




Description
Get A Quote

Expression System        CHO

Aggregation                     < 5% as determined by SEC-HPLC

Purity                                > 95% as determined by SDS-PAGE

Endotoxin                        < 1 EU/mg, determined by LAL gel clotting assay

Sterility                             0.2 μm Filtered

Target                              IL-12& IL-23

Clone                                Ustekinumab

Source/Isotype               Monoclonal Human IgG1, Kappa

Application                      /

Description                  Ustekinumab (brand name: Stelara) is a fully human IgG1κ monoclonal antibody developed by Janssen Biotech, a subsidiary of Johnson & Johnson. It is used to treat various immune-mediated diseases, such as psoriasis, psoriatic arthritis, and Crohn's disease. It exerts its immunomodulatory effects by specifically inhibiting the activity of the pro-inflammatory cytokines IL-12 and IL-23.

Formulation                 phosphate-buffered solution, pH 7.4.




Data
Get A Quote

image.png

image.png


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current position:Product Center > -- > Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
classify
Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
Product Info
Get A Quote

Cat. No:GM-87870MAB

Product:Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)


Cat. No. & Size
Get A Quote

GM-87870MAB-1mg / 1 mg

GM-87870MAB-5mg / 5 mg

GM-87870MAB-25mg / 25 mg

GM-87870MAB-50mg / 50 mg

GM-87870MAB-100mg / 100 mg




Description
Get A Quote

Expression System        CHO

Aggregation                     < 5% as determined by SEC-HPLC

Purity                                > 95% as determined by SDS-PAGE

Endotoxin                        < 1 EU/mg, determined by LAL gel clotting assay

Sterility                             0.2 μm Filtered

Target                              IL-12& IL-23

Clone                                Ustekinumab

Source/Isotype               Monoclonal Human IgG1, Kappa

Application                      /

Description                  Ustekinumab (brand name: Stelara) is a fully human IgG1κ monoclonal antibody developed by Janssen Biotech, a subsidiary of Johnson & Johnson. It is used to treat various immune-mediated diseases, such as psoriasis, psoriatic arthritis, and Crohn's disease. It exerts its immunomodulatory effects by specifically inhibiting the activity of the pro-inflammatory cytokines IL-12 and IL-23.

Formulation                 phosphate-buffered solution, pH 7.4.




Data
Get A Quote

image.png

image.png


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit